Lu Lin

Title: Innovations of Lu Lin in Autoimmune Myocarditis Research

Introduction

Lu Lin is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of autoimmune myocarditis through his innovative research and patent.

Latest Patents

Lu Lin holds a patent for a mouse model of myocarditis. This patent describes a preparation method for an anti-PD-1/PD-L1 monoclonal antibody (mAb)-induced autoimmune myocarditis model. The method includes mediating a model with adeno-associated virus 9 (AAV9) to achieve high expression of PDL1 in myocardial tissue. Additionally, it involves applying an anti-PD-1/PD-L1 mAb to the model with high PDL1 expression in the myocardial tissue for effective modeling. The model prepared by this method accurately simulates the pathogenesis and clinical course of autoimmune myocarditis in patients administered with an anti-PD1/PD-L1 mAb. It closely resembles the pathophysiological status of clinical patients, boasts a high modeling rate, and allows for dynamic monitoring.

Career Highlights

Lu Lin is affiliated with Peking Union Medical College Hospital, where he continues to advance his research in the medical field. His work has garnered attention for its potential impact on understanding and treating autoimmune conditions.

Collaborations

Lu Lin collaborates with notable colleagues, including Yining Wang and Chanjuan Qu, who contribute to his research endeavors.

Conclusion

Lu Lin's innovative work in developing a mouse model for autoimmune myocarditis represents a significant advancement in medical research. His contributions are poised to enhance the understanding and treatment of autoimmune diseases.